Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2015 Apr 1;60(2):179–189. doi: 10.1515/ap-2015-0026

Antiparasitic DNA vaccines in 21st century

Halina Wedrychowicz 1,✉
PMCID: PMC7088677  PMID: 26203983

Abstract

Demands for effective vaccines to control parasitic diseases of humans and livestock have been recently exacerbated by the development of resistance of most pathogenic parasites to anti-parasitic drugs. Novel genomic and proteomic technologies have provided opportunities for the discovery and improvement of DNA vaccines which are relatively easy as well as cheap to fabricate and stable at room temperatures. However, their main limitation is rather poor immunogenicity, which makes it necessary to couple the antigens with adjuvant molecules. This paper review recent advances in the development of DNA vaccines to some pathogenic protozoa and helminths. Numerous studies were conducted over the past 14 years of 21st century, employing various administration techniques, adjuvants and new immunogenic antigens to increase efficacy of DNA vaccines. Unfortunately, the results have not been rewarding. Further research is necessary using more extensive combinations of antigens; alternate delivery systems and more efficient adjuvants based on knowledge of the immunomodulatory capacities of parasitic protozoa and helminths.

Keywords: DNA vaccines, adjuvants, exprimental trials, immunomodulation

References

  1. Ahmad G, Torren W, Zhang W, Wyatt M, Siddiqui AA. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni. Parasite Immunology. 2009;31:156–161. doi: 10.1111/j.1365-3024.2008.01091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahmad G, Zhang W, Torben W, Damian RT, Chavez-Suarez M, Wolf RF, White GL. Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine. 2009;27:2830–2837. doi: 10.1016/j.vaccine.2009.02.096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ahmad G, Zhang W, Torben W, Haskins C, Diggs S, Noor Z, Le L, Siddiqui AA. Prime/boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitology Research. 2009;105:1767–1777. doi: 10.1007/s00436-009-1646-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anand SB, Murugan V, Prabhu PR, Anandharaman V, Reddy MV, Kaliraj P. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) inmice. Acta Tropica. 2008;107:106–112. doi: 10.1016/j.actatropica.2008.04.018. [DOI] [PubMed] [Google Scholar]
  5. Anand SB, Kodumudi KN, Reddy MV, Kaliraj P. A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds. Journal of Helminthology. 2011;85:442–452. doi: 10.1017/S0022149X10000799. [DOI] [PubMed] [Google Scholar]
  6. Bergman PJ, Camps-Palau MA, McKnight JA, Leibman NF, Craft DM, Leung C, Liao J, Riviere I, Sadelain M, Hohenhaus AE, Gregor P, Houghton AN, Perales MA, Wolchok JD. Development of a xenogenetic DNA vaccine program for canine malignantmelanoma at the Animal Medical Center. Vaccine. 2006;24:4582–4585. doi: 10.1016/j.vaccine.2005.08.027. [DOI] [PubMed] [Google Scholar]
  7. Bolhassani A, Gholami E, Zahedifard F, Moradin N, Parsi P, Doustdari F, Seyed N, Papadopoulou B, Rafati S. Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model. Experimental Parasitology. 2011;128:9–17. doi: 10.1016/j.exppara.2011.01.012. [DOI] [PubMed] [Google Scholar]
  8. Cao S, Mousa AA, Aboge GO, Kamyingkird K, Zhou M, Moumouni PFA, Terkawi MA, Masatani T, Nishikawa Y, Suzuki H, Fukumoto S, Xuan X. Prime-boost vaccinationwith plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs. Acta Parasitologica. 2013;58:619–623. doi: 10.2478/s11686-013-0183-1. [DOI] [PubMed] [Google Scholar]
  9. Cannas A, Naguleswaran A, Muller N, Eperon S, Gottstein B, Hemphill A. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology. 2003;126:303–312. doi: 10.1017/s0031182002002895. [DOI] [PubMed] [Google Scholar]
  10. Chlichlia K, Bahgat M, Ruppel A, Schirrmacher V. DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice. Vaccine. 2001;20:439–447. doi: 10.1016/s0264-410x(01)00345-0. [DOI] [PubMed] [Google Scholar]
  11. Cruz Lança AS, de Sousa KP, Atouguia J, Prazeres DMF, Monteiro GA, Silva MS. Trypanosoma brucei: Immunisation with plasmid DNA encoding invariant surface glycoprotein gene is able to induce partial protection in experimental African trypanosomiasis. Experimental Parasitology. 2011;127:18–24. doi: 10.1016/j.exppara.2010.06.017. [DOI] [PubMed] [Google Scholar]
  12. Da’dara AA, Skelly PJ, Fatakawadala M, Visovatti S, Eriksson E, Harn DA. Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery. Parasite Immunology. 2002;24:179–187. doi: 10.1046/j.1365-3024.2002.00453.x. [DOI] [PubMed] [Google Scholar]
  13. Da’Dara AA, Li YS, Xiong T Z J, Williams GM, McManus DP, Fenge Z, Yu XL, Gray DJ, Harn DA. DNAbased vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine. 2008;26:3617–3625. doi: 10.1016/j.vaccine.2008.04.080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dalton JP, Robinson MW, Mulcahy G, O’Neill SM, Donnelly S. Immunomodulatory molecules of Fasciola hepatica. Veterinary Parasitology. 2013;195:272–285. doi: 10.1016/j.vetpar.2013.04.008. [DOI] [PubMed] [Google Scholar]
  15. Davidson AH, Traub-Dargatz JL, Rodeheaver RM, Ostlund EN, Pedersen DD, Moorhead RG, Stricklin JB, Dewell RD, Roach SD, Long RE, Albers SJ, Callan RJ, Salman MD. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. Journal of the American Veterinary Medical Association. 2005;226:240–245. doi: 10.2460/javma.2005.226.240. [DOI] [PubMed] [Google Scholar]
  16. Dobano C, Rogers WO, Gowda K, Doolan DL. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines. Immunology Letters. 2007;111:92–102. doi: 10.1016/j.imlet.2007.05.007. [DOI] [PubMed] [Google Scholar]
  17. Du A, Wang S. Efficacy of a DNA vaccine delivered in attenuated Salmonella typhimurium against Eimeria tenella infection in chickens. International Journal forParasitology. 2005;35:777–785. doi: 10.1016/j.ijpara.2005.03.005. [DOI] [PubMed] [Google Scholar]
  18. Dunachie SJ, Walther M, Epstein JE, Keating S, Berthoud T A L, Andersen RF, Bejon P, Goonetilleke N, Poulton I, Webster DP, Butcher G, Watkins K, Sinden RE, Levine GL R TL, Schneider J, Kaslow D, Gilbert SC, Carucci DJ, Hill AVS. A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding ThrombospondinRelated Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge. Infection and Immunity. 2006;74:5933–5942. doi: 10.1128/IAI.00590-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Espino A.M., Morales A., Delgado B., Rivera F.M., Figueroa O., Suárez E. 2010. Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct. Ethnicity & Disease, 20, S1-17-23 [PMC free article] [PubMed]
  20. Fukumoto F, Tamaki Y, Igarashi I, Suzuki H, Xuan X. Immunogenicity and growth inhibitory efficacy of the prime-boost immunization regime with DNA followed by recombinant vaccinia virus carrying the P29 gene of Babesia gibsoni in dogs. Experimental Parasitology. 2009;123:296–301. doi: 10.1016/j.exppara.2009.08.012. [DOI] [PubMed] [Google Scholar]
  21. Garver KA, LaPatra SE, Kurath G. Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon. Diseases of Aquatic Organisms. 2005;64:13–22. doi: 10.3354/dao064013. [DOI] [PubMed] [Google Scholar]
  22. Geriletu Xu L, Xurihu Li X. Vaccination of chickens with DNA vaccine expressing Eimeria tenella MZ5-7 against coccidiosis. Veterinary Parasitology. 2011;177:6–12. doi: 10.1016/j.vetpar.2010.11.041. [DOI] [PubMed] [Google Scholar]
  23. Han K, Xu L, Yan R, Song X, Li X. Vaccination of goats with glyceraldehyde-3-phosphate dehydrogenase DNA vaccine induced partial protection against Haemonchus contortus. Veterinary Immunology and Immunopathology. 2012;149:177–185. doi: 10.1016/j.vetimm.2012.06.016. [DOI] [PubMed] [Google Scholar]
  24. He S, Yang L, Lv Z, Hu W, Cao J, Wei J, Sun X, Zheng H, Wu Z. Molecular and functional characterization of a mortalin-like protein from Schistosoma japonicum (SjMLP/hsp70) as a member of the HSP70 family. Parasitology Research. 2010;107:955–966. doi: 10.1007/s00436-010-1960-5. [DOI] [PubMed] [Google Scholar]
  25. Hezarjaribi HZ, Ghaffarifar F, Dalimi F, Sharifi Z, Jorjani O. Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice. Experimental Parasitology. 2013;134:341–348. doi: 10.1016/j.exppara.2013.03.012. [DOI] [PubMed] [Google Scholar]
  26. Hiszczynska-Sawicka E, Olędzka G, Holec-Gąsior L, Li H X JB, Sedcole R, Kur J, Bickerstaffe R, Stankiewicz M. Evaluation of immune responses in sheep inducedby DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii. Veterinary Parasitology. 2011;177:281–289. doi: 10.1016/j.vetpar.2010.11.047. [DOI] [PubMed] [Google Scholar]
  27. Hiszczynska-Sawicka E, Li H, Xua JB, Holec-Gąsior L, Kur J, Sedcole R, Bickerstaffe R, Stankiewicz M. Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154. Veterinary Parasitology. 2011;183:72–78. doi: 10.1016/j.vetpar.2011.06.010. [DOI] [PubMed] [Google Scholar]
  28. Januszkiewicz K. Optimalization of vaccination against Fasciola hepatica infections using cDNA encoding for selected fluke antigens and specific for the host species CTLA-4 molecule. 2010. [Google Scholar]
  29. Jaros S, Jaros D, Wesolowska A, Zygner W, Wedrychowicz H. Blocking Fasciola hepatica’s energy metabolism - a pilot study of vaccine potential of a novel gene - phosphoglycerate kinase. Veterinary Parasitology. 2010;172:229–237. doi: 10.1016/j.vetpar.2010.05.008. [DOI] [PubMed] [Google Scholar]
  30. Jayaraj R, Piedrafita D, Spithill T, Smooker P. Evaluation of the immune responses induced by four targeted DNA vaccines encoding the juvenile liver fluke antigen, cathepsin B in a mouse model. Genetic Vaccines and Therapy. 2012;10:2–7. doi: 10.1186/1479-0556-10-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jenkins M, Parker C T W, Vinyard B, Dubey JP. Inclusion of CpG adjuvant with plasmid DNA coding for NcGRA7 improves protection against congenital neosporosis. 2004;72:1817–1819. doi: 10.1128/IAI.72.3.1817-1819.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kalyanasundaram R, Balumuri P. Research and Reports in Tropical Medicine. 2011. Multivalent vaccine formulation with BmVAL-1 and BmALT-2 confer significant protection against challenge infections with Brugia malayi in mice and jirds; pp. 45–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kennedy NJ, Spithill TW, Tennent J, Wood PR, Piedrafita D. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy. Vaccine. 2006;24:970–979. doi: 10.1016/j.vaccine.2005.08.076. [DOI] [PubMed] [Google Scholar]
  34. Kimani D, Jagne YJ, Cox M, Kimani E, Bliss CM G E, Ogwang C, Afolabi MO, Bowyer G, Collins KA, et al. Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. Molecular Therapy. 2014;22:1992–2003. doi: 10.1038/mt.2014.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. Journal of Immunology, 158, 3635-3642 [PubMed]
  36. Kofta W, Wędrychowicz H. c-DNA vaccination against parasitic infections: advantages and disadvantages. Veterinary Parasitology. 2001;94:243–247. doi: 10.1016/s0304-4017(01)00478-2. [DOI] [PubMed] [Google Scholar]
  37. Kurup SP, Tewari AK. Induction of protective immune response in mice by a DNA vaccine encoding Trypanosoma evansi beta tubulin gene. Veterinary Parasitology. 2012;187:9–16. doi: 10.1016/j.vetpar.2012.01.009. [DOI] [PubMed] [Google Scholar]
  38. Lee JS, Kim IS, Sohn WM, Lee J, Yong TS. A DNA vaccine encoding a fatty acid binding protein of Clonorchis sinensis induces protective immune response in Sprague-Dawley rats. Scandinavian Journal of Immunology. 2006;63:169–176. doi: 10.1111/j.1365-3083.2006.01721.x. [DOI] [PubMed] [Google Scholar]
  39. Lee J, Kim IS, Sohn W, Lee J, Yong T. Vaccination with DNA encoding cysteine proteinase confers protective immune response to rats infected with Clonorchis sinensis. Vaccine. 2006;24:2358–2366. doi: 10.1016/j.vaccine.2005.11.062. [DOI] [PubMed] [Google Scholar]
  40. Levine MM, Sztein MB. Vaccine development strategies for improving immunization: The role of modern immunology. Nature Immunology. 2004;5:460–464. doi: 10.1038/ni0504-460. [DOI] [PubMed] [Google Scholar]
  41. Li M, Lei J WangT, Lu S, Guan F, Liu W, Li Y. Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum. Experimental Parasitology. 2011;128:427–432. doi: 10.1016/j.exppara.2011.05.012. [DOI] [PubMed] [Google Scholar]
  42. Liddell S, Parker C, Vinyard B, Jenkins M, Dubey JP. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum. Journal of Parasitology. 2003;89:496–500. doi: 10.1645/GE-2969. [DOI] [PubMed] [Google Scholar]
  43. Liu MA. DNA vaccines: An historical perspective and view to the future. Immunological Reviews. 2010;239:62–84. doi: 10.1111/j.1600-065X.2010.00980.x. [DOI] [PubMed] [Google Scholar]
  44. Liu Q, Shang L, Jin H WeiF, Zhu Q, Gao H. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18. Research in Veterinary Science. 2010;89:93–97. doi: 10.1016/j.rvsc.2010.01.007. [DOI] [PubMed] [Google Scholar]
  45. Mancini-Bourgine M, Fontaine H, Brechot C, Pol S, Michel ML. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine. 2006;24:4482–4489. doi: 10.1016/j.vaccine.2005.08.013. [DOI] [PubMed] [Google Scholar]
  46. Masih S, Arora SK, Vasishta RK. Efficacy of Leishmania donovani ribosomal P1 gene asDNA vaccine in experimental visceral leishmaniasis. Experimental Parasitology. 2011;129:55–64. doi: 10.1016/j.exppara.2011.05.014. [DOI] [PubMed] [Google Scholar]
  47. Martin JE, Louder MK, Holman LA, Gordon IJ E M, Larkin BD, et al. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial. Vaccine. 2008;26:6338–6343. doi: 10.1016/j.vaccine.2008.09.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. McCullers JA. Evolution, benefits, and shortcomings of vaccine management. Journal of Managed Care Pharmacy. 2007;13:S2–S6. doi: 10.18553/jmcp.2007.13.s7-b.2a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Mc Neilly TN, Nisbet AJ. Immune modulation by helminth parasites of ruminants: implications for vaccine development and host immune competence. Parasite. 2014;21:51–62. doi: 10.1051/parasite/2014051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Molloy M, Bouladoux N, Belkaid Y. Intestinal microbiota: shaping local and systemic immune responses. Seminar in Immunology. 2012;24:51–55. doi: 10.1016/j.smim.2011.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Nielsen HV D, Cristina M, Beghetto E, Spadoni A, Petersen E, Gargano N. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts. Experimental Parasitology. 2006;112:274–279. doi: 10.1016/j.exppara.2005.11.009. [DOI] [PubMed] [Google Scholar]
  52. Payette PJ, Weeratna RD, McCluskie MJ, Davis HL. Immunemediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms. Gene Therapy. 2001;8:1395–1400. doi: 10.1038/sj.gt.3301534. [DOI] [PubMed] [Google Scholar]
  53. Person R, Bodles-Brakhop AM, Pope MA, Brown PA, Khan AS, Draghia-Akli R. Growth hormone-releasing hormone plasmid treatment by electroporation decreases offspring mortality over three pregnancies. Molecular Therapy. 2008;16:1891–1897. doi: 10.1038/mt.2008.178. [DOI] [PubMed] [Google Scholar]
  54. Qu D, Han J, Du A. Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice Parasitology Research. 2013;112:2593–2599. doi: 10.1007/s00436-013-3425-0. [DOI] [PubMed] [Google Scholar]
  55. Rafati S, Zahedifard F, Azari MK, Taslimi Y, Taheri T. Leishmania infantum: Prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice. Experimental Parasitology. 2008;118:393–401. doi: 10.1016/j.exppara.2007.10.004. [DOI] [PubMed] [Google Scholar]
  56. Rainczuk A, Scorza T, Spithill TW, Smooker PM. A bicistronic DNA vaccine containing Apical Membrane Antigen 1 and Merozoite Surface Protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria. Infection and Immunity. 2004;72:5565–5573. doi: 10.1128/IAI.72.10.5565-5573.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Rathaur S, Yadav M, Gupta S, Anandharaman V, Reddy MV. Filarial glutathione-S-transferase: a potential vaccine candidate against lymphatic filariasis. Vaccine. 2008;26:4094–4100. doi: 10.1016/j.vaccine.2008.03.099. [DOI] [PubMed] [Google Scholar]
  58. Robinson MW, Dalton JP, O’Brien BA, Donnelly S. Fasciola hepatica: The therapeutic potential of a worm secretome. International Journal for Parasitology. 2013;43:283–291. doi: 10.1016/j.ijpara.2012.11.004. [DOI] [PubMed] [Google Scholar]
  59. Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Review of Vaccines. 2012;11:189–209. doi: 10.1586/erv.11.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen M, Silverman GJ, Lotz M, Carson DA, Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 1996;273:352–354. doi: 10.1126/science.273.5273.352. [DOI] [PubMed] [Google Scholar]
  61. Shah MAA, Yan R, Xu L, Song X, Li X. A recombinant DNA vaccine encoding Eimeria acervulina cSZ-2 induces immunity against experimental E. tenella infection. Veterinary Parasitology. 2010;169:185–189. doi: 10.1016/j.vetpar.2009.12.035. [DOI] [PubMed] [Google Scholar]
  62. Shah MAA, Song X X L, Yan R, Li X. Construction of DNA vaccines encoding Eimeria acervulina cSZ-2 with chicken IL-2 and IFN-c and their efficacy against poultry coccidiosis. Research in Veterinary Science. 2011;90:72–77. doi: 10.1016/j.rvsc.2010.05.003. [DOI] [PubMed] [Google Scholar]
  63. Shi W, Liu Q, Zhang J, Sun J, Jiang X, Geng J, Wang F, Xiao Y, Li H, Zhao X. Co-expression of EtMic2 protein and chicken interleukin-18 for DNA vaccine against chicken coccidiosis. Research in Veterinary Science. 2014;97:64–70. doi: 10.1016/j.rvsc.2014.05.001. [DOI] [PubMed] [Google Scholar]
  64. Smooker PM, Kennedy NJ, Steeper KR, Christopoulos H, Spithill TW. Fasciola: Kinetics and quality of humoral responses to fatty acid binding protein and cathepsin l following delivery as DNA vaccines in mice. Experimental Parasitology. 2001;97:154–160. doi: 10.1006/expr.2001.4601. [DOI] [PubMed] [Google Scholar]
  65. Song X, Xu L, Yan R, Huang X, Shah MAA, Li X. The optimal immunization procedure of DNA vaccine pcDNA-TA4-IL-2 of Eimeria tenella and its cross-immunity to Eimeria necatrix and Eimeria acervulina. Veterinary Parasitology. 2009;159:30–36. doi: 10.1016/j.vetpar.2008.10.015. [DOI] [PubMed] [Google Scholar]
  66. Song H, Yan R, Xu L, Song X, Shah MAA, Zhu H, Li X. Efficacy of DNA vaccines carrying Eimeria acervulina lactate dehydrogenase antigen gene against coccidiosis. Experimental Parasitology. 2010;126:224–231. doi: 10.1016/j.exppara.2010.05.015. [DOI] [PubMed] [Google Scholar]
  67. Song H, Qiu B, Yan R, Xu L, Song X, Li X. The protective efficacy of chimeric SO7/IL-2 DNA vaccine against coccidiosis in chickens. Research in Veterinary Science. 2013;94:562–567. doi: 10.1016/j.rvsc.2012.11.006. [DOI] [PubMed] [Google Scholar]
  68. Schneider J, Langermans JA, Gilbert SC, Blanchard TJ, Twigg S, Naitza S, Hannan CM, Aidoo M, Crisanti A, Robson KJ, et al. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. Vaccine. 2001;19:4595–4602. doi: 10.1016/s0264-410x(01)00260-2. [DOI] [PubMed] [Google Scholar]
  69. Sun W, Song X, Yan R, Xu L, Li X. Vaccination of goats with a glutathione peroxidase DNA vaccine induced partial protection against Haemonchus contortus infection. Veterinary Parasitology. 2011;182:239–247. doi: 10.1016/j.vetpar.2011.05.024. [DOI] [PubMed] [Google Scholar]
  70. Thirugnanam S, Pandiaraja P, Ramaswamy K, Murugan V, Gnanasekar M, Nanadakumar K, Reddy MV, Kaliraj P. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Experimental Parasitology. 2007;116:483–491. doi: 10.1016/j.exppara.2007.02.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology. 2007;6:475–490. doi: 10.1016/j.imbio.2007.03.009. [DOI] [PubMed] [Google Scholar]
  72. Vaughan EE, Dean DA. Intracellular trafficking of plasmids during transfection is mediated by microtubules. Molecular Therapy. 2006;13:422–428. doi: 10.1016/j.ymthe.2005.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Waine GJ, Alarcon JB, McManus DP. Genetic immunization of mice with DNA encoding the 23 kDa transmembrane surface protein of Schistosoma japonicum (Sj23) induces antigen-specific immunoglobulin G antibodies. Parasite Immunology. 2002;21:377–381. doi: 10.1046/j.1365-3024.1999.00221.x. [DOI] [PubMed] [Google Scholar]
  74. Wang H, He S, Yao Y, Cong H, Zha H, Li T, Zhu X. Toxoplasma gondii: Protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice. Experimental Parasitology. 2009;122:226–232. doi: 10.1016/j.exppara.2009.04.002. [DOI] [PubMed] [Google Scholar]
  75. Wahren W, Liu MA. Vaccines. 2014. DNA vaccines: recent developments and the future. [DOI] [PubMed] [Google Scholar]
  76. Wesołowska A, Norbury L, Januszkiewicz K, Jedlina L, Jaros S, Zawistowska-Deniziak A ZygnerW, Wędrychowicz H. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1) Acta Parasitologica. 2013;58:198–206. doi: 10.2478/s11686-013-0120-3. [DOI] [PubMed] [Google Scholar]
  77. Wedrychowicz H, Szymanski P, Panasiuk LJ, Bienkowska-Szewczyk K. Humoral immune response of rats vaccinated with cDNA or protein form of glutathione-S-transferase of Fasciola hepatica to infection with metacercariae of the fluke. Helminthologia. 2002;39:127–133. [Google Scholar]
  78. Wędrychowicz H, Lamparska M, Kęsik M, Kotomski G, Mieszczanek J, Jedlina-Panasiuk L, Płucienniczak A. The immune response of rats to vaccination with cDNA or protein forms of the cysteine proteinase of Fasciola hepatica. Veterinary Immunology and Immunopathology. 2003;94:83–93. doi: 10.1016/s0165-2427(03)00085-0. [DOI] [PubMed] [Google Scholar]
  79. Williams JA. Vector Design for Improved DNA Vaccine Efficacy, Safety and Production. Vaccines. 2013;1:225–249. doi: 10.3390/vaccines1030225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Wiśniewski M, Jaros S, Bąska P, Capello M, Wędrychowicz H. Ancylostoma ceylanicum metalloprotease 6 DNA vaccination induces partial protection against hookworm challenge infection. Acta Parasitologica. 2013;58:376–383. doi: 10.2478/s11686-013-0151-9. [DOI] [PubMed] [Google Scholar]
  81. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465–1468. doi: 10.1126/science.1690918. [DOI] [PubMed] [Google Scholar]
  82. Xiang W, Qiong Z, Li-peng L, Kui T, Jian-wu G, Heng-ping S. The location of invasion-related protein MIC3 of Toxoplasma gondii and protective effect of its DNA vaccine in mice. Veterinary Parasitology. 2009;166:1–7. doi: 10.1016/j.vetpar.2009.08.014. [DOI] [PubMed] [Google Scholar]
  83. Xu Q, Song X, Xu L, Yan R, Shah M, Li X. Vaccination of chickens with a chimeric DNA vaccine encoding Eimeria tenella TA4 and chicken IL-2 induces protective immunity against coccidiosis. Veterinary Parasitology. 2008;156:319–323. doi: 10.1016/j.vetpar.2008.05.025. [DOI] [PubMed] [Google Scholar]
  84. Xue M, He S, Zhang J, Cui Y, Yao Y, Wang H. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. Experimental Parasitology. 2008;119:352–357. doi: 10.1016/j.exppara.2008.03.005. [DOI] [PubMed] [Google Scholar]
  85. Xue M, He S, Zhang J, Cui Y, Yao Y, Wang H. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Parasitology International. 2008;57:424–429. doi: 10.1016/j.parint.2008.05.001. [DOI] [PubMed] [Google Scholar]
  86. Yamakami K, Akao S, Sato M, Nitta Y, Miyazaki J, Tadakuma T. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB c mice from Leishmania major infection. Parasitology International. 2001;50:81–91. doi: 10.1016/s1383-5769(01)00070-8. [DOI] [PubMed] [Google Scholar]
  87. Yan H, Yuan Z, Petersen E, Zhang X, Zhou D, Liu Q, He Y, Lin R, Xu M, Chen X, Zhong X, Zhu X. Toxoplasma gondii: Protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1. Experimental Parasitology. 2011;128:38–43. doi: 10.1016/j.exppara.2011.02.005. [DOI] [PubMed] [Google Scholar]
  88. Yan R, Sun W, Song X, Li X. Vaccination of goats with DNA vaccine encoding Dim-1 induced partial protection against Haemonchus contortus: A preliminary experimental study. Research in Veterinary Science. 2013;95:189–199. doi: 10.1016/j.rvsc.2013.02.020. [DOI] [PubMed] [Google Scholar]
  89. You Z, Huang X, Hester J, Toh HC, Chen SY. Targeting dendritic cells to enhance DNA vaccine potency. Cancer Research. 2001;61:3704–3711. [PubMed] [Google Scholar]
  90. Yu Q, Li J, Zhang X, Gong P, Zhang P, Li S, Wang H. Induction of immune responses in mice by a DNA vaccine encoding Cryptosporidium parvum Cp12 and Cp21 and its effect against homologous oocyst challenge. Veterinary Parasitology. 2010;172:1–7. doi: 10.1016/j.vetpar.2010.04.036. [DOI] [PubMed] [Google Scholar]
  91. Yu L, Yamagishi J, Zhang S, Jin Ch, Aboge OG, Zhang H, Zhang G, Tanaka T, Fujisaki K, Nishikawa Y, Xuan X. Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitology International. 2012;61:481–486. doi: 10.1016/j.parint.2012.04.001. [DOI] [PubMed] [Google Scholar]
  92. Yuan H, You-en S, Long-jiang Y, Xiao-hua Z, Liu-zhe L, Cash M, Lu Z, Zhi L, Deng-xin S. Studies on the protective immunity of Schistosoma japonicum bivalent DNA vaccine encoding Sj23 and Sj14. Experimental Parasitology. 2006;115:379–386. doi: 10.1016/j.exppara.2006.09.022. [DOI] [PubMed] [Google Scholar]
  93. Zhao Y, Bao Y, Zhang L, Chang L, Jiang L, Liu Y, Zhang L, Qin J. Biosafety of the plasmid pcDNA3-1E of Eimeria acervulina in chicken. Experimental Parasitology. 2013;133:231–236. doi: 10.1016/j.exppara.2012.11.026. [DOI] [PubMed] [Google Scholar]
  94. Zhao G, Yan R, Muleke CI, Sun Y, Xu L, Li X. Vaccination of goats with DNA vaccines encoding H11 and IL-2 induces partial protection against Haemonchus contortus infection. Veterinary Journal. 2012;191:94–100. doi: 10.1016/j.tvjl.2010.12.023. [DOI] [PubMed] [Google Scholar]
  95. Zhu Y, Lu F, Dai Y, Wang X, Tang J, Zhao S, Zhang Ch, Zhang H, Lu S, Wang S. Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines. Vaccine. 2010;28:5347–5355. doi: 10.1016/j.vaccine.2010.05.017. [DOI] [PubMed] [Google Scholar]
  96. Zhu L, Liu H, Lu M, Long Q, Shi Y, Yu L. Construction, purification, and evaluation of multivalent DNA vaccine against. Schistosoma japonicum Parasitology Research. 2011;108:115–121. doi: 10.1007/s00436-010-2040-6. [DOI] [PubMed] [Google Scholar]

Articles from Acta Parasitologica are provided here courtesy of Nature Publishing Group

RESOURCES